Publications

Coronary artery interventions in the setting of Immune Thrombocytopaenic Purpura (ITP) carry the twin risks of bleeding and thrombosis related to the mandatory dual anti-platelet therapy. This condition therefore may require a splenectomy prior to the coronary intervention. Surgical splenectomy in the presence of high-grade coronary stenosis carries greater morbidity and mortality. We report here a unique solution to this therapeutic dilemma, which was splenic artery embolisation followed by percutaneous coronary intervention (PCI).